Compile Data Set for Download or QSAR
Report error Found 174 Enz. Inhib. hit(s) with all data for entry = 157
TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 260242BDBM260242(US9522914, A-44)
Affinity DataIC50: 0.160nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 260267BDBM260267(US9522914, B-20)
Affinity DataIC50: 0.430nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 260241BDBM260241(US9522914, A-43)
Affinity DataIC50: 0.490nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 260347BDBM260347(US9522914, D-36)
Affinity DataIC50: 0.610nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 260206BDBM260206(US9522914, A-08)
Affinity DataIC50: 0.820nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 260237BDBM260237(US9522914, A-39)
Affinity DataIC50: 1nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 260248BDBM260248(US9522914, B-01)
Affinity DataIC50: 1.40nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 260264BDBM260264(US9522914, B-17)
Affinity DataIC50: 1.40nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 260329BDBM260329(US9522914, D-18)
Affinity DataIC50: 1.5nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 260308BDBM260308(US9522914, C-19)
Affinity DataIC50: 2.20nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 260256BDBM260256(US9522914, B-09)
Affinity DataIC50: 2.20nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 260249BDBM260249(US9522914, B-02)
Affinity DataIC50: 2.20nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 260213BDBM260213(US9522914, A-15)
Affinity DataIC50: 2.40nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 260316BDBM260316(US9522914, D-05)
Affinity DataIC50: 2.5nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 260220BDBM260220(US9522914, A-22)
Affinity DataIC50: 2.60nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 260352BDBM260352(US9522914, D-41)
Affinity DataIC50: 2.70nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 260341BDBM260341(US9522914, D-30)
Affinity DataIC50: 2.80nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 260255BDBM260255(US9522914, B-08)
Affinity DataIC50: 2.80nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 260342BDBM260342(US9522914, D-31)
Affinity DataIC50: 2.90nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 260219BDBM260219(US9522914, A-21)
Affinity DataIC50: 3.20nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 260334BDBM260334(US9522914, D-23)
Affinity DataIC50: 3.30nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 260253BDBM260253(US9522914, B-06)
Affinity DataIC50: 3.30nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 260345BDBM260345(US9522914, D-34)
Affinity DataIC50: 3.30nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 260224BDBM260224(US9522914, A-26)
Affinity DataIC50: 3.40nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 260324BDBM260324(US9522914, D-13)
Affinity DataIC50: 3.5nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 260225BDBM260225(US9522914, A-27)
Affinity DataIC50: 3.60nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 260208BDBM260208(US9522914, A-10)
Affinity DataIC50: 3.70nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 260200BDBM260200(US9522914, A-02)
Affinity DataIC50: 3.70nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 260300BDBM260300(US9522914, C-11)
Affinity DataIC50: 3.90nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 260328BDBM260328(US9522914, D-17)
Affinity DataIC50: 3.90nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 260254BDBM260254(US9522914, B-07)
Affinity DataIC50: 4.30nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 260301BDBM260301(US9522914, C-12)
Affinity DataIC50: 4.30nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 260337BDBM260337(US9522914, D-26)
Affinity DataIC50: 4.40nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 260317BDBM260317(US9522914, D-06)
Affinity DataIC50: 4.60nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 260325BDBM260325(US9522914, D-14)
Affinity DataIC50: 4.70nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 260258BDBM260258(US9522914, B-11)
Affinity DataIC50: 5.10nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 260338BDBM260338(US9522914, D-27)
Affinity DataIC50: 5.30nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 260263BDBM260263(US9522914, B-16)
Affinity DataIC50: 5.30nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 260318BDBM260318(US9522914, D-07)
Affinity DataIC50: 5.5nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 260259BDBM260259(US9522914, B-12)
Affinity DataIC50: 6.30nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 260240BDBM260240(US9522914, A-42)
Affinity DataIC50: 6.30nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 260299BDBM260299(US9522914, C-10)
Affinity DataIC50: 6.5nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 260261BDBM260261(US9522914, B-14)
Affinity DataIC50: 6.60nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 260266BDBM260266(US9522914, B-19)
Affinity DataIC50: 6.90nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 260323BDBM260323(US9522914, D-12 | US9522914, d-38)
Affinity DataIC50: 7nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 260321BDBM260321(US9522914, D-10)
Affinity DataIC50: 7.10nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 260296BDBM260296(US9522914, C-07)
Affinity DataIC50: 7.10nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 260265BDBM260265(US9522914, B-18)
Affinity DataIC50: 7.20nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 260251BDBM260251(US9522914, B-04)
Affinity DataIC50: 7.40nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

TargetVasopressin V1b receptor(Human)
Taisho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 260332BDBM260332(US9522914, D-21)
Affinity DataIC50: 7.5nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
US Patent

Displayed 1 to 50 (of 174 total ) | Next | Last >>
Jump to: